Company Search:
Advanced Search
Sponsored Links
UCB Sa Company Snapshot
UCB Sa operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares UCB Sa with three other pharmaceutical manufacturers in Europe: Stada Arzneimittel AG of Germany (2017 sales of 2.31 billion Euro [US$2.62 billion] of which 59% was Generics), Protek PAO of Russia (258.45 billion Russian Rubles [US$3.88 billion] of which 78% was Distribution), and Lonza Group AG which is based in Switzerland (5.11 billion Swiss Francs [US$5.12 billion] of which 47% was Specialty Ingredients).

Sales Analysis. UCB Sa reported sales of 4.53 billion Euro (US$5.14 billion) for the year ending December of 2017. This represents an increase of 8.4% versus 2016, when the company's sales were 4.18 billion Euro. This was the third consecutive year of growth at UCB Sa.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
  Stock Performance Chart for UCB Sa
  Stock Data: Recent Stock Performance:
  Current Price (12/7/2018): 75.40
(Figures in Euro)
1 Week 1.6%   13 Weeks -0.6%  
4 Weeks -3.1%   52 Weeks 17.7%  
UCB Sa Key Data:
  Ticker: UCB Country: Belgium
  Exchanges: BRU Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2017 Sales 4,530,000,000
(Year Ending Jan 2018).
Employees: 7,478
  Currency: Euro Market Cap: 14,184,390,431
  Fiscal Yr Ends: December Shares Outstanding: 188,121,889
  Share Type: Actions Ordinaires Closely Held Shares: 71,662,112
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.